Loading…

The Primary Result of Prospective Randomized Multicenter Trial of New Spray-Type Bio-absorbable Adhesion Barrier System (TCD-11091) Against Postoperative Adhesion Formation

Background Postoperative adhesions are the major cause of postoperative complications including intestinal obstruction, infertility, and chronic pelvic pain. In order to reduce postoperative adhesions, Terumo Corporation (Tokyo, Japan) has developed an adhesion barrier system (TCD-11091) which is ea...

Full description

Saved in:
Bibliographic Details
Published in:Journal of gastrointestinal surgery 2017-10, Vol.21 (10), p.1683-1691
Main Authors: Suto, Takeshi, Watanabe, Masahiko, Endo, Takeshi, Komori, Koji, Ohue, Masayuki, Kanemitsu, Yukihide, Itou, Masaaki, Takii, Yasumasa, Yatsuoka, Toshimasa, Shiozawa, Manabu, Kinugasa, Tetsushi, Ueno, Hideki, Takayama, Tadatoshi, Masaki, Tadahiko, Masuko, Hiroyuki, Horie, Hisanaga, Inomata, Masafumi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Postoperative adhesions are the major cause of postoperative complications including intestinal obstruction, infertility, and chronic pelvic pain. In order to reduce postoperative adhesions, Terumo Corporation (Tokyo, Japan) has developed an adhesion barrier system (TCD-11091) which is easy to use at the treatment site in various surgical procedures including laparoscopic surgeries. We conducted a prospective randomized single-blind study in patients who underwent laparotomy with ileostomy. Methods and Results One hundred twenty-six patients were randomly assigned to TCD-11091 group ( n  = 62) or non-treatment group ( n  = 62). Patient backgrounds were similar between the groups. At the time of ileostomy closure (the second-look surgery), the observation was performed on 55 in the TCD-11091 group and 43 in the control group. The incidence of adhesions observed at the second-look surgery was significantly lower in the TCD-11091 group (52.7 versus 90.7%; p  
ISSN:1091-255X
1873-4626
DOI:10.1007/s11605-017-3503-1